Narimatsu Y, Bull C, Chen Y, Wandall H, Yang Z, Clausen H
J Biol Chem. 2021; 296:100448.
PMID: 33617880
PMC: 8042171.
DOI: 10.1016/j.jbc.2021.100448.
Tian W, Ye Z, Wang S, Schulz M, Van Coillie J, Sun L
Nat Commun. 2019; 10(1):1785.
PMID: 31040271
PMC: 6491494.
DOI: 10.1038/s41467-019-09809-3.
Farhadi S, Bracho-Sanchez E, Freeman S, Keselowsky B, Hudalla G
Bioconjug Chem. 2017; 29(3):649-656.
PMID: 29285931
PMC: 5993548.
DOI: 10.1021/acs.bioconjchem.7b00719.
Deegan P, Cox T
Drug Des Devel Ther. 2012; 6:81-106.
PMID: 22563238
PMC: 3340106.
DOI: 10.2147/DDDT.S14395.
Goker-Alpan O
Ther Clin Risk Manag. 2010; 6:315-23.
PMID: 20668714
PMC: 2909498.
DOI: 10.2147/tcrm.s6955.
Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.
Sola R, Griebenow K
BioDrugs. 2010; 24(1):9-21.
PMID: 20055529
PMC: 2805475.
DOI: 10.2165/11530550-000000000-00000.
Receptor-mediated gene transfer into macrophages.
Ferkol T, Perales J, Mularo F, Hanson R
Proc Natl Acad Sci U S A. 1996; 93(1):101-5.
PMID: 8552583
PMC: 40186.
DOI: 10.1073/pnas.93.1.101.
A biochemical and immunocytochemical study on the targeting of alglucerase in murine liver.
Willemsen R, Tibbe J, Kroos M, Martin B, Reuser A, Ginns E
Histochem J. 1995; 27(8):639-46.
PMID: 8550385
Lysosomal storage diseases: mechanisms of enzyme replacement therapy.
Bou-Gharios G, Abraham D, Olsen I
Histochem J. 1993; 25(9):593-605.
PMID: 8226100
DOI: 10.1007/BF00157873.
Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease.
Brady R, Murray G, Barton N
J Inherit Metab Dis. 1994; 17(4):510-9.
PMID: 7967500
DOI: 10.1007/BF00711365.
A histochemical study about the zonal distribution of the galactose-binding protein in rat liver.
HARDONK M, Scholtens H
Histochemistry. 1980; 69(3):289-97.
PMID: 7440265
DOI: 10.1007/BF00489774.
Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.
Barton N, Furbish F, Murray G, Garfield M, Brady R
Proc Natl Acad Sci U S A. 1990; 87(5):1913-6.
PMID: 2308952
PMC: 53594.
DOI: 10.1073/pnas.87.5.1913.
Alglucerase. A review of its therapeutic use in Gaucher's disease.
Whittington R, Goa K
Drugs. 1992; 44(1):72-93.
PMID: 1379912
DOI: 10.2165/00003495-199244010-00007.
An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. I. Distribution of 125I-ligands among the liver cell types.
Hubbard A, Wilson G, ASHWELL G, Stukenbrok H
J Cell Biol. 1979; 83(1):47-64.
PMID: 511941
PMC: 2110443.
DOI: 10.1083/jcb.83.1.47.
Endocytosis of lysosomal enzymes by non-parenchymal rat liver cells. Comparative study of lysosomal-enzyme uptake by hepatocytes and non-parenchymal liver cells.
Ullrich K, Gieselmann V, Mersmann G, von Figura K
Biochem J. 1979; 182(2):329-35.
PMID: 508287
PMC: 1161311.
DOI: 10.1042/bj1820329.
Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro.
Dale G, KUHL W, Beutler E
Proc Natl Acad Sci U S A. 1979; 76(1):473-5.
PMID: 284362
PMC: 382963.
DOI: 10.1073/pnas.76.1.473.
Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.
Desnick R, Dean K, Grabowski G, Bishop D, Sweeley C
Proc Natl Acad Sci U S A. 1979; 76(10):5326-30.
PMID: 228284
PMC: 413135.
DOI: 10.1073/pnas.76.10.5326.
Recognition of human urine alpha-N-acetylglucosaminidase by rat hepatocytes. Involvement of receptors specific for galactose, mannose 6-phosphate and mannose.
Ullrich K, Basner R, Gieselmann V, von Figura K
Biochem J. 1979; 180(2):413-9.
PMID: 114170
PMC: 1161066.
DOI: 10.1042/bj1800413.
Specific binding of 125I-labeled beta-hexosaminidase A to rat brain synaptosomes.
Kusiak J, Toney J, Quirk J, Brady R
Proc Natl Acad Sci U S A. 1979; 76(2):982-5.
PMID: 85305
PMC: 383113.
DOI: 10.1073/pnas.76.2.982.